|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 07-08 | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 07-07 | US FDA approves Vera's kidney disease drug | RE |
Upcoming events on NOVARTIS
| 2026-07-21 | Earnings release - Q2 2026 | |
| 2026-10-27 | Earnings release - Q3 2026 |
Past events on NOVARTIS
| 2026-04-28 | Earnings release - Q1 2026 | |
| 2026-04-28 | Earnings presentation | 08:00 |
| 2026-03-06 | Annual General Meeting | 04:00 |
| 2026-03-06 | Présentation aux Actionnaires / Analystes | 04:00 |
| 2026-02-04 | Earnings presentation | 08:00 |
| 2026-02-03 | Earnings release - Q4 2025 | |
| 2025-12-01 | Information meeting | 10:00 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 04:15 |
| 2025-11-20 | Présentation aux Actionnaires / Analystes | 03:00 |
| 2025-10-30 | Information meeting | 11:30 |
| 2025-10-28 | Earnings presentation | 09:00 |
| 2025-10-27 | Earnings release - Q3 2025 | |
| 2025-07-17 | Earnings presentation | 08:00 |
| 2025-07-16 | Earnings release - Q2 2025 |
Past dividends on NOVARTIS
| 2026-03-10 | Ex-dividend date - 3.7 CHF | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46 660 46 810 -0.32% | 51 722 50 407 2.61% | 56 674 55 618 1.9% | 56 864 | 60 301 | 63 983 |
|
EBITDA Million USD | Released Forecast Spread | 17 937 18 223 -1.57% | 21 006 19 819 5.99% | 23 415 23 671 -1.08% | 23 501 | 25 357 | 27 529 |
|
EBIT Million USD | Released Forecast Spread | 16 372 16 735 -2.17% | 19 494 18 983 2.69% | 21 889 21 846 0.19% | 21 492 | 23 293 | 25 237 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 123 10 323 -11.63% | 13 640 13 560 0.59% | 16 352 17 360 -5.81% | 15 746 | 18 287 | 20 531 |
|
Net income Million USD | Released Forecast Spread | 14 854 10 329 43.8% | 11 939 11 438 4.38% | 13 967 14 570 -4.14% | 14 079 | 15 643 | 17 519 |
|
EPS USD | Released Forecast Spread | 7,15 5,38 32.95% | 5,92 5,53 7% | 7,21 7,16 0.7% | 7,16 | 8,45 | 9,78 |
| Announcement Date | 31/01/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 172 12 666 4% | 13 558 12 823 5.73% | 13 620 13 116 3.85% | 14 836 14 136 4.95% | 14 358 13 866 3.55% | 13 860 14 077 -1.54% | 13 524 13 480 0.33% | 14 118 | 14 519 | 14 918 | 14 015 | 14 430 | 14 690 | 14 825 |
|
EBITDA Million USD | Released Forecast Spread | 5 294 | 5 338 4 861 9.81% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | 5 145 4 892 5.16% | 4 859 4 435 9.56% | 5 575 5 272 5.75% | 5 925 5 827 1.68% | 5 460 5 520 -1.08% | 4 929 5 010 -1.62% | 4 897 5 215 -6.1% | 5 380 | 5 649 | 5 626 | 5 465 | 5 680 | 5 730 | 5 720 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 385 4 028 -15.96% | 3 285 3 478 -5.55% | 4 196 4 238 -0.99% | |||||||||||
|
Net income Million USD | Released Forecast Spread | 3 189 3 197 -0.25% | 2 820 2 585 9.08% | 3 606 3 255 10.78% | 4 024 3 909 2.93% | 3 930 3 652 7.61% | 2 404 2 414 -0.4% | 3 156 3 227 -2.21% | 3 314 | 3 356 | 3 537 | ||||
|
EPS USD | Released Forecast Spread | 1,58 1,48 7.03% | 1,42 1,30 9.63% | 1,83 1,65 10.96% | 2,07 1,99 3.77% | 2,04 1,87 9.02% | 1,26 1,26 0.23% | 1,65 1,68 -2.07% | 1,73 | 1,76 | 1,87 | ||||
| Announcement Date | 29/10/24 | 31/01/25 | 29/04/25 | 17/07/25 | 28/10/25 | 04/02/26 | 28/04/26 | - | - | - | - | - | - | - |
| 2026-07-13 | Ex-dividend date - 0.77711 EUR | 00:00 | |
| 2026-07-15 | Earnings release - Q2 2026 | 06:45 | |
| 2026-07-15 | Earnings presentation | 08:30 | |
| 2026-07-15 | Ex-dividend date - 1.73 USD | 00:00 | |
| 2026-07-15 | Earnings release - Q2 2026 | ||
| 2026-07-15 | Earnings presentation | 08:00 | |
| 2026-07-15 | Extraordinary General Meeting | 02:30 | |
| 2026-07-16 | Extraordinary General Meeting | 02:00 | |
| 2026-07-16 | Extraordinary General Meeting | 02:30 | |
| 2026-07-17 | Ex-dividend date - 18 INR | 00:00 |
Past sector events for NOVARTIS
| 2026-07-10 | Ex-dividend date - 8 INR | 00:00 | |
| 2026-07-10 | Extraordinary General Meeting | 02:00 | |
| 2026-07-10 | Extraordinary General Meeting | 02:00 | |
| 2026-07-10 | Ex-dividend date - 0.17248 HKD | 00:00 | |
| 2026-07-10 | Présentation aux Actionnaires / Analystes | 01:30 | |
| 2026-07-10 | Annual General Meeting | 01:30 | |
| 2026-07-09 | Information meeting | 07:00 | |
| 2026-07-09 | Earnings presentation | 02:00 | |
| 2026-07-09 | Ex-dividend date - 0.15 CNY | 00:00 | |
| 2026-07-09 | Ex-dividend date - 0.28 CNY | 00:00 |
- Stock Market
- Stocks
- NOVN Stock
- 0HKE Stock
- Calendar NOVARTIS
Select your edition
All financial news and data tailored to specific country editions
















